NZMP at ESPGHAN 2019
New findings on MFGM proteins help us narrow the compositional and functional gap between breast milk and infant formula.
NZMP presented new research into MFGM proteins at ESPGHAN 2019
European Society for Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN)
Meet our team of experts
Dr James Dekker
Programme Manager, Nutrition NTD - New Zealand
Dr James Dekker started his career as a medical researcher studying immunology and genetics, with stints at the Australian National University in Canberra and the John Radcliffe Hospital in Oxford, England.
For the last 20 years Dr Dekker has been working at Fonterra on probiotics and other bioactive ingredients including MFGM Lipids. During this time, he has been instrumental in shaping our clinical research in the probiotics space and has been the author of numerous peer reviewed articles.
Dr Dekker is leading the development of strategic research programmes to understand the benefits of NZMP’s ingredients for paediatric and maternal health.
Senior Research Scientist, Food Design & Analysis - New Zealand
Bertram Fong is a senior research scientist, based in the Fonterra Research and Development Centre in Palmerston North, who has worked for Fonterra for close to 30 years.
He has a Master of Science (MSc) in Analytical Chemistry. As an analytical chemist, he has been at the forefront of developing the test methods for measuring the components of MFGM including their detailed chemical composition.
His most recent work on the proteins of MFGM has been presented at a number of high-profile scientific conferences. He continues to focus on the composition of breast milk and characterising MFGM proteins to further understand it better and potentially add these components into infant formula.
Associate Research Scientist, Food Design & Analysis - New Zealand
Kevin Ma is an associate research scientist, with a Master of Science (MSc) in Biochemistry.
Having been with Fonterra for 10 years, Kevin has a breadth of research experience on bio-active compounds such as phospholipids, gangliosides, oligosaccharides, cerebrosides and MFGM protein/peptides. His work on analytical methods has supported the wider programme of MFGM research including breastmilk, pre-clinical, and clinical studies and product surveys.
Kevin has been the author of several publications focused on MFGM Lipids in international journals, published under his Chinese name, Lin Ma.